Skip to content

Research at St Andrews

Obtaining tissue diagnosis in lung cancer patients with poor performance status and its influence on treatment and survival

Research output: Contribution to journalArticlepeer-review

Open Access permissions




John D. Maclay, John M.B. Farley, Colin McCowan, Conor Tweed, Robert Milroy

School/Research organisations


Introduction: 25% of patients with lung cancer have performance status 3 or 4. A pragmatic approach to investigative procedures is often adopted based on the risks and benefits in these patients and whether tissue diagnosis is necessary for anticipated future treatment. This cohort study investigated factors influencing a clinician's decision to pursue a tissue diagnosis in patients with lung cancer and performance status 3 and 4 and to examine the association of tissue diagnosis with subsequent management and survival.

Methods: All patients with lung cancer diagnosed in North Glasgow from 2009 to 2012 were prospectively recorded in a registry. We investigated the relationships between achieving a tissue diagnosis, treatment and survival.

Results: Of 2493 patients diagnosed with lung cancer, 490 patients (20 were PS 3 and 122 patients (5 were PS 4. Tissue diagnosis was attempted in 60% and 35% patients with PS 3 and PS 4 respectively. Younger age, better performance status and having stage 4 disease were independently associated with a diagnostic procedure being performed. Only 5% of patients with poor performance status received treatment conventionally requiring a tissue diagnosis. Age, stage and performance status were independent predictors of mortality. Achieving a tissue diagnosis was not associated with mortality. Receiving treatment requiring tissue diagnosis is associated with survival benefit.

Conclusions: The majority of patients with poor fitness undergo a diagnostic procedure which does not influence further treatment or affect survival. However, the cohort of patients who do undergo therapy determined by tissue diagnosis have improved survival.


Original languageEnglish
Pages (from-to)30-35
Number of pages6
JournalRespiratory Medicine
Early online date13 Jan 2017
Publication statusPublished - Mar 2017

    Research areas

  • Lung cancer, Performance status, Histology, Mortality

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

    Vasileiou, E., Simpson, C. R., Shi, T., Kerr, S., Agrawal, U., Akbari, A., Bedston, S., Beggs, J., Bradley, D., Chuter, A., de Lusignan, S., Docherty, A. B., Ford, D., Hobbs, FD. R., Joy, M., Katikireddi, S. V., Marple, J., McCowan, C., McGagh, D., McMenamin, J. & 12 others, Moore, E., Murray, J. LK., Pan, J., Ritchie, L., Shah, S. A., Stock, S., Torabi, F., Tsang, R. SM., Wood, R., Woolhouse, M., Robertson, C. & Sheikh, A., 23 Apr 2021, In: The Lancet. 397, 10285, p. 1646-1657

    Research output: Contribution to journalArticlepeer-review

  2. Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality

    Flook, M., Jackson, C., Vasileiou, E., Simpson, C. R., Muckian, M. D., Agrawal, U., McCowan, C., Jia, Y., Murray, J. L. K., Ritchie, L. D., Robertson, C., Stock, S. J., Wang, X., Woolhouse, M. E. J., Sheikh, A. & Stagg, H. R., 12 Apr 2021, In: BMC Infectious Diseases. 21, 23 p., 342.

    Research output: Contribution to journalArticlepeer-review

  3. Medication adherence, utilisation of healthcare services and mortality of patients with epilepsy on opiate replacement therapy: a retrospective cohort study

    Askarieh, A., Morrison, I., Ross, K., McCowan, C., Matthews, K., Kidd, B. & Heath, C. A., Apr 2021, In: Epilepsy & Behaviour. 117, 4 p., 107829.

    Research output: Contribution to journalArticlepeer-review

  4. Changes over time in the management of long-term conditions in primary health-care for adults with intellectual disabilities, and the health-care inequalities gap

    Hughes-McCormack, L., Greenlaw, N., McSkimming, P., McCowan, C., Ross, K., Allan, L., Henderson, A., Melville, C., Morrison, J. & Cooper, S-A., Mar 2021, In: Journal of Applied Research in Intellectual Disabilities. 34, 2, p. 634-647

    Research output: Contribution to journalArticlepeer-review

  5. Cohort profile: early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II) database

    Mulholland, R. H., Vasileiou, E., Simpson, C. R., Ritchie, L. D., Agrawal, U., Woolhouse, M., Murray, J. L. K., Stagg, H. R., Docherty, A. B., McCowan, C., Wood, R., Stock, S. J. & Sheikh, A., 29 Jan 2021, (Accepted/In press) In: International Journal of Epidemiology.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. Effect of hospital asthma nurse appointment on inpatient asthma care

    Smith, E., Alexander, V., Booker, C., Mccowan, C., Ogston, S. & Mukhopadhyay, S., 1 Jan 2000, In: Respiratory Medicine. 94, 1, p. 82-86 5 p.

    Research output: Contribution to journalArticlepeer-review

  2. Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulations of inhaled beclomethasone

    Lipworth, B. J. & Jackson, C. M., Feb 2000, In: Respiratory Medicine. 94, 2, p. 177-177 1 p.

    Research output: Contribution to journalLetterpeer-review

ID: 257573615